Center for Drug Evaluation and Research Director Patrizia Cavazzoni’s retirement deepens a US Food and Drug Administration leadership void that has emerged ahead of President-elect Donald Trump’s inauguration and could herald a much larger wave of departures so the new administration could install its preferred candidates.
CDER Director Patrizia Cavazzoni Retires
Corrigan-Curay Named Acting Director
Cavazzoni, who led the drugs center four-and-a-half years, decided on her own to retire at this time, sources said. The decision may have been a preemptive move knowing her time as head of CDER would have been limited, or at the very least highly challenging, under the new administration.
